The magic of small-molecule drugs during ex vivo expansion in adoptive cell therapy by Hanwen Zhang, Tenzin Passang, Sruthi Ravindranathan, Ramireddy Bommireddy, Ramireddy Bommireddy, Mohammad Raheel Jajja, Lily Yang, Lily Yang, Periasamy Selvaraj, Periasamy Selvaraj, Chrystal M. Paulos, Chrystal M. Paulos, Chrystal M. Paulos, Edmund K. Waller, Edmund K. Waller

Get full text

The Great Debate at ‘Immunotherapy Bridge’, Naples, December 5, 2019 by Jerome Galon, Chrystal M Paulos, Sergio A Quezada, Hussein A Tawbi

Get full text

Genomics meets immunity in pancreatic cancer: Current research and future directions for pancreatic adenocarcinoma immunotherapy by Jacob S. Bowers, Stefanie R. Bailey, Mark P. Rubinstein, Chrystal M. Paulos, E. Ramsay Camp

Get full text

CAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies by Hannah M. Knochelmann, Hannah M. Knochelmann, Aubrey S. Smith, Aubrey S. Smith, Connor J. Dwyer, Connor J. Dwyer, Megan M. Wyatt, Megan M. Wyatt, Shikhar Mehrotra, Shikhar Mehrotra, Chrystal M. Paulos, Chrystal M. Paulos

Get full text

916 Making their own off switch: Fgl2 produced by antigen-specific CD8+ T cells tempers the CD8+ T-cell response via apoptosis of FcγRIIB+ CD8+ T cells by Chrystal M Paulos, Megan M Wyatt, Kelsey B Bennion, Danya Liu, Abdelhameed Dawood, Mosalah S Abdel-Hakeem, Mandy L Ford

398 Utilizing a Th17 polarization strategy for generating high quality human TIL products for patients with advanced solid tumors by Gregory B Lesinski, Keith A Delman, Chrystal M Paulos, Hannah M Knochelmann, Megan M Wyatt, Michael C Lowe, Soundharya Kumaresan

Immunological effects of nivolumab immunotherapy in patients with oral cavity squamous cell carcinoma by Ying Xiong, David M. Neskey, Joshua D. Horton, Chrystal M. Paulos, Hannah M. Knochelmann, Kent E. Armeson, M. Rita I. Young

Get full text

267 Adapting orthotopic murine models of pancreatic cancer to enhance adoptive T cell immunotherapy by Gregory B Lesinski, Chrystal M Paulos, Cameron Herting, Maggie Phillips, Megan M Wyatt, Natalie K Horvat, Jacklyn Hammons, Isaac Karpovsky, Zaid Mahdi

A dhesion analysis via a tumor vasculature-like microfluidic device identifies CD8+ T cells with enhanced tumor homing to improve cell therapy by Camila P. Camargo, Abir K. Muhuri, Yunus Alapan, Lauren F. Sestito, Megha Khosla, Margaret P. Manspeaker, Aubrey S. Smith, Chrystal M. Paulos, Susan N. Thomas

Get full text

Fueling Cancer Immunotherapy With Common Gamma Chain Cytokines by Connor J. Dwyer, Connor J. Dwyer, Hannah M. Knochelmann, Hannah M. Knochelmann, Aubrey S. Smith, Aubrey S. Smith, Megan M. Wyatt, Megan M. Wyatt, Guillermo O. Rangel Rivera, Guillermo O. Rangel Rivera, Dimitrios C. Arhontoulis, Dimitrios C. Arhontoulis, Eric Bartee, Zihai Li, Mark P. Rubinstein, Mark P. Rubinstein, Chrystal M. Paulos, Chrystal M. Paulos

Get full text

Fundamentals of T Cell Metabolism and Strategies to Enhance Cancer Immunotherapy by Guillermo O. Rangel Rivera, Guillermo O. Rangel Rivera, Guillermo O. Rangel Rivera, Hannah M. Knochelmann, Hannah M. Knochelmann, Hannah M. Knochelmann, Connor J. Dwyer, Aubrey S. Smith, Aubrey S. Smith, Aubrey S. Smith, Megan M. Wyatt, Megan M. Wyatt, Amalia M. Rivera-Reyes, Amalia M. Rivera-Reyes, Jessica E. Thaxton, Jessica E. Thaxton, Chrystal M. Paulos, Chrystal M. Paulos

Get full text

823 Repurposing CD26/DPP4 inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinoma by Thomas Mace, Gregory B Lesinski, Chrystal M Paulos, Michael Ware, Olatunji Alese, Juan Sarmiento, Shishir Maithel, Maggie Phillips, Megan M Wyatt, Natalie K Horvat, Jacklyn Hammons, Bassel FEl Reyes

Programmed death 1 (PD‐1) and ligand (PD‐L1) inhibitors in head and neck squamous cell carcinoma: A meta‐analysis by Dylan A. Levy, Jaimin J. Patel, Shaun A. Nguyen, W. Nicholas Jungbauer, David M. Neskey, Ezra E. W. Cohen, Chrystal M. Paulos, John A. Kaczmar, Hannah M. Knochelmann, Terry A. Day

Get full text

Potential clinical implications of CD4+CD26high T cells for nivolumab treated melanoma patients by Domenico Galati, Serena Zanotta, Mariaelena Capone, Gabriele Madonna, Domenico Mallardo, Marilena Romanelli, Ester Simeone, Lucia Festino, Francesca Sparano, Rosa Azzaro, Rosaria De Filippi, Antonio Pinto, Chrystal M. Paulos, Paolo A. Ascierto

Get full text

1507 The Galectin-9-Tim-3 pathway is a novel checkpoint target for patients with biliary tract cancer by Yuan Liu, Gregory B Lesinski, Chrystal M Paulos, Shishir Maithel, Brian Robinson, Megan M Wyatt, Jacklyn Hammons, Emilie AK Warren, Jessica Keilson, Guillermo O Rangel-Rivera, Caroline R Goel, Curtis J Henry, Sarah Kulkarni, Alyssa Krasinskas

353 Adoptively transferred Th17 cells engage host B cells for durable tumor destruction by Gregory B Lesinski, Chrystal M Paulos, Bhavana Pavuluri, Aubrey S Smith, Hannah M Knochelmann, Megan M Wyatt, Guillermo O Rangel Rivera, Amalia M Rivera-Reyes, Anna C Cole, Soundharya Kumaresan, Megen Wittling, Ayana T Ruffin, Jeremy M Boss

B cells imprint adoptively transferred CD8+ T cells with enhanced tumor immunity by Mark P Rubinstein, Bei Liu, Eric Bartee, Chrystal M Paulos, Jessica E Thaxton, Aubrey S Smith, Hannah M Knochelmann, Megan M Wyatt, Guillermo O Rangel Rivera, Amalia M Rivera-Reyes, Connor J Dwyer, Michael B Ware, Anna C Cole, David M Neskey

Get full text

Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer by Shikhar Mehrotra, Carolyn D. Britten, Steve Chin, Elizabeth Garrett-Mayer, Colleen A. Cloud, Mingli Li, Gina Scurti, Mohamed L. Salem, Michelle H. Nelson, Melanie B. Thomas, Chrystal M. Paulos, Andres M. Salazar, Michael I. Nishimura, Mark P. Rubinstein, Zihai Li, David J. Cole

Get full text

Modeling ex vivo tumor-infiltrating lymphocyte expansion from established solid malignancies by Hannah M Knochelmann, Amalia M Rivera-Reyes, Megan M Wyatt, Aubrey S Smith, Reilley Chamness, Connor J Dwyer, Michael Bobian, Guillermo O Rangel Rivera, Joshua D Horton, Michael Lilly, Martin J Romeo, Cynthia D Timmers, Mark P Rubinstein, David M Neskey, Chrystal M Paulos

Get full text

629 Neoadjuvant SEMA4D inhibitor pepinemab combination with nivolumab increases crosstalk between B cell and CD26hi T cell in patients with resectable stage III melanoma by Brian Burns, Elizabeth Evans, Ragini Kudchadkar, Crystal Mallow, Christine Reilly, Maurice Zauderer, Gregory B Lesinski, Keith A Delman, Chrystal M Paulos, Brian Olson, Terrence Fisher, Jayden Kim, Michael C Lowe, Ayana T Ruffin, Jacklyn Hammons, Agnes Harutyunyan, Melinda Yushak, Ali Mokhtari, Douglas Parker